Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton Sep 01, 2021 12:20pm
308 Views
Post# 33794652

RE:RE:RE:MD&A For your viewing pleasure !

RE:RE:RE:MD&A For your viewing pleasure !It's really remarkable that 2 of the first 3 patients that received the full dose were still cancer-free after 2 years. How is this not a cure?

Even saying '67% of the first 3 were cured' may mislead one to underestimate the efficacy of the treatment as the patient who was not cured had pre-existing and non-Study related metastatic cancer and could not have been cured in the trial.

The undertreatment of the first 12 patients of the phase 2 trial has seriously distorted the efficacy data. Despite this, efficacy data to-date is impressive and is being progressively rectified as more and more patients are treated.

enriquesuave wrote:

WOW!  Just noticed that, PH1 patients 5 & 6 cancer free at up to 24 months after only one single treatment.  Let's hope we see a majority of those PH2 optimized treated patients do as well.

 

cashascars wrote: Is it just early in the morning with no coffee or was this the first time they mentioned patients 5&6 from phase 1 with one treatment were cancer free at 24 months. I thought the last we heard it was 18 months.
Either way its so unbelievably that 1433 is works so well that 1 treatment can have such impact on patients that struggled with their cancer so much that they were at the end of any hope except to enter a Trial of a PDT drug that had no track record of success until they took the risk. Now they reap the rewards of their bravery and TLD 1433 success.
Thanks to Sherri Mac. And Tharalase 
cashascars

 

 



<< Previous
Bullboard Posts
Next >>